Exact Oncology™
A clinically-proven testing portfolio that provides insights throughout the entire cancer care continuum.
A single portfolio.
A full spectrum of insights.
A full spectrum of insights.
Screening & treatment guidance
Testing that offers genomic intelligence specific to a patient’s tumor biology.
Recurrence monitoring
Testing that monitors therapy response and tracks evidence of cancer recurrence, progression, or regression.
Therapy selection
Testing that delivers curated therapy options for each individual patient.
Transform treatment with our test combinations
Our flexible product suites leverage the tests within our portfolio to give providers deeper insights, so they can create more timely and customized treatment plans for their patients.
Early Breast Cancer Diagnostic Suite
Oncotype DX Breast Recurrence Score® test
A tumor-tissue early-stage breast cancer test that shows how likely cancer will return somewhere else in the body and predicts the benefit of chemotherapy
Cancer type:
Breast
Test type:
Treatment guidance
Treatment guidance tests show how likely cancer might come back and/or how beneficial specific treatments might be to help inform care decisions.
Sample type:
Tumor tissue
Oncodetect® test
A tumor-informed test that can detect circulating tumor DNA in the blood during or after cancer treatment
Cancer type:
All solid tumors
Test type:
Monitoring, MRD
Monitoring tests look for molecular residual disease (MRD), hard-to-find traces of cancer called circulating tumor DNA (ctDNA) that might be present in blood.
Sample type:
Blood, tumor tissue
Riskguard® test
A blood or saliva test that can uncover hereditary risk for certain cancers and help inform treatment decisions
Cancer type:
Multiple
- Breast cancer
- Colorectal cancer
- Endocrine cancer
- Endometrial cancer
- Gastric cancer
- Kidney cancer
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Skin cancer
Test type:
Hereditary cancer
Hereditary cancer tests reveal the risk of developing certain cancers to help inform screening and aid prevention. They can also help guide treatment and therapy selection in patients with cancer.
Sample type:
Blood, cheek swab, saliva
More than 1.9 million patients have used Oncotype DX® to help guide their treatment decisions.*
Advanced Cancer Diagnostic Suite
Pairing comprehensive genomic profiling (CGP) and molecular residual disease (MRD) tests can help you form more proactive and personalized care strategies for your patients with late-stage cancer.
Oncodetect® test
A tumor-informed test that can detect circulating tumor DNA in the blood during or after cancer treatment
Cancer type:
All solid tumors
Test type:
Monitoring, MRD
Monitoring tests look for molecular residual disease (MRD), hard-to-find traces of cancer called circulating tumor DNA (ctDNA) that might be present in blood.
Sample type:
Blood, tumor tissue
OncoExTra® test
A tumor-tissue test that provides therapy selection guidance for advanced solid tumor cancers
Cancer type:
All solid tumors
Test type:
Therapy selection
Therapy selection tests provide a look into a tumor's unique makeup. They highlight key information to select therapies and/or clinical trials that may help.
Sample type:
Blood, tumor tissue
Riskguard® test
A blood or saliva test that can uncover hereditary risk for certain cancers and help inform treatment decisions
Cancer type:
Multiple
- Breast cancer
- Colorectal cancer
- Endocrine cancer
- Endometrial cancer
- Gastric cancer
- Kidney cancer
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Skin cancer
Test type:
Hereditary cancer
Hereditary cancer tests reveal the risk of developing certain cancers to help inform screening and aid prevention. They can also help guide treatment and therapy selection in patients with cancer.
Sample type:
Blood, cheek swab, saliva
Our Exact Oncology portfolio
Screening & treatment guidance
Recurrence monitoring
Therapy selection
- Test in development; not commercially available.
Cancer care that’s innovative by design
We’re moving beyond single-point tests to deliver a full continuum of insights — from identifying hereditary risk to detecting recurrence earlier than imaging.1 Our connected approach will help clinicians stay one step ahead of cancer.
Provider support that makes light work of your workflow
Exact Oncology provides the support necessary for top-tier workflows, including placing and managing test orders, tracking results, and accessing reports — all in one digital Provider Hub. The platform also gives you visibility across your entire practice, plus technical support, right at your fingertips.